Glycemic responses of three mango varieties in subjects with and without T2D: a pilot crossover study using OTT and CGM

Mango consumption is often restricted in diet consumed by people with diabetes due to concerns about its glycemic impact. This study aimed to compare the glycemic effects of mango consumption with those of white bread and glucose in subjects with and without type 2 diabetes (T2D). We conducted a two...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical nutrition Vol. 79; no. 10; p. 991
Main Authors: Kehar, Sugandha, Bhatt, Surya Prakash, Pandey, Ravindra M, Ahmad Ansari, Irshad, Palavalli, Rajashekar Reddy, Gupta, Vimal, Misra, Anoop
Format: Journal Article
Language:English
Published: England 01.10.2025
Subjects:
ISSN:1476-5640, 1476-5640
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Mango consumption is often restricted in diet consumed by people with diabetes due to concerns about its glycemic impact. This study aimed to compare the glycemic effects of mango consumption with those of white bread and glucose in subjects with and without type 2 diabetes (T2D). We conducted a two-phase study involving 95 participants (45 with T2D, 50 non-diabetic). Phase 1 employed oral tolerance test (OTT) to assess immediate glycemic responses to mango (Safeda, Dasheri, and Langra), bread, and glucose. Phase 2 utilized continuous glucose monitoring (CGM) to evaluate glycemic profiles over three days. On OTT, in non-diabetic subjects, mango consumption resulted in non-significantly lower postprandial glucose peaks compared to glucose and bread, except Langra variety which showed lowest area under the curve for glucose of borderline significance. In subjects with T2D, mango varieties performed similarly to bread. CGM data revealed that mango consumption over three days resulted in a similar glycemic profile to bread in non-diabetic subjects and a lower glycemic profile in subjects with T2D, though most differences were statistically not significant. Mean Amplitude of Glycemic Excursion (MAGE) was significantly lower after mango ingestion as compared to bread in CGM data in subjects with T2D. Data show limited glycemic impact of tested mango varieties, comparable to or lower than white bread, especially in T2D subjects. The significant reduction in MAGE observed with mango consumption suggests potential benefits for glycemic variability. With portion control in calorie restrictive diets, mango may be suitable for people with T2D.
AbstractList Mango consumption is often restricted in diet consumed by people with diabetes due to concerns about its glycemic impact. This study aimed to compare the glycemic effects of mango consumption with those of white bread and glucose in subjects with and without type 2 diabetes (T2D).OBJECTIVESMango consumption is often restricted in diet consumed by people with diabetes due to concerns about its glycemic impact. This study aimed to compare the glycemic effects of mango consumption with those of white bread and glucose in subjects with and without type 2 diabetes (T2D).We conducted a two-phase study involving 95 participants (45 with T2D, 50 non-diabetic). Phase 1 employed oral tolerance test (OTT) to assess immediate glycemic responses to mango (Safeda, Dasheri, and Langra), bread, and glucose. Phase 2 utilized continuous glucose monitoring (CGM) to evaluate glycemic profiles over three days.METHODSWe conducted a two-phase study involving 95 participants (45 with T2D, 50 non-diabetic). Phase 1 employed oral tolerance test (OTT) to assess immediate glycemic responses to mango (Safeda, Dasheri, and Langra), bread, and glucose. Phase 2 utilized continuous glucose monitoring (CGM) to evaluate glycemic profiles over three days.On OTT, in non-diabetic subjects, mango consumption resulted in non-significantly lower postprandial glucose peaks compared to glucose and bread, except Langra variety which showed lowest area under the curve for glucose of borderline significance. In subjects with T2D, mango varieties performed similarly to bread. CGM data revealed that mango consumption over three days resulted in a similar glycemic profile to bread in non-diabetic subjects and a lower glycemic profile in subjects with T2D, though most differences were statistically not significant. Mean Amplitude of Glycemic Excursion (MAGE) was significantly lower after mango ingestion as compared to bread in CGM data in subjects with T2D.RESULTSOn OTT, in non-diabetic subjects, mango consumption resulted in non-significantly lower postprandial glucose peaks compared to glucose and bread, except Langra variety which showed lowest area under the curve for glucose of borderline significance. In subjects with T2D, mango varieties performed similarly to bread. CGM data revealed that mango consumption over three days resulted in a similar glycemic profile to bread in non-diabetic subjects and a lower glycemic profile in subjects with T2D, though most differences were statistically not significant. Mean Amplitude of Glycemic Excursion (MAGE) was significantly lower after mango ingestion as compared to bread in CGM data in subjects with T2D.Data show limited glycemic impact of tested mango varieties, comparable to or lower than white bread, especially in T2D subjects. The significant reduction in MAGE observed with mango consumption suggests potential benefits for glycemic variability. With portion control in calorie restrictive diets, mango may be suitable for people with T2D.CONCLUSIONSData show limited glycemic impact of tested mango varieties, comparable to or lower than white bread, especially in T2D subjects. The significant reduction in MAGE observed with mango consumption suggests potential benefits for glycemic variability. With portion control in calorie restrictive diets, mango may be suitable for people with T2D.
Mango consumption is often restricted in diet consumed by people with diabetes due to concerns about its glycemic impact. This study aimed to compare the glycemic effects of mango consumption with those of white bread and glucose in subjects with and without type 2 diabetes (T2D). We conducted a two-phase study involving 95 participants (45 with T2D, 50 non-diabetic). Phase 1 employed oral tolerance test (OTT) to assess immediate glycemic responses to mango (Safeda, Dasheri, and Langra), bread, and glucose. Phase 2 utilized continuous glucose monitoring (CGM) to evaluate glycemic profiles over three days. On OTT, in non-diabetic subjects, mango consumption resulted in non-significantly lower postprandial glucose peaks compared to glucose and bread, except Langra variety which showed lowest area under the curve for glucose of borderline significance. In subjects with T2D, mango varieties performed similarly to bread. CGM data revealed that mango consumption over three days resulted in a similar glycemic profile to bread in non-diabetic subjects and a lower glycemic profile in subjects with T2D, though most differences were statistically not significant. Mean Amplitude of Glycemic Excursion (MAGE) was significantly lower after mango ingestion as compared to bread in CGM data in subjects with T2D. Data show limited glycemic impact of tested mango varieties, comparable to or lower than white bread, especially in T2D subjects. The significant reduction in MAGE observed with mango consumption suggests potential benefits for glycemic variability. With portion control in calorie restrictive diets, mango may be suitable for people with T2D.
Author Palavalli, Rajashekar Reddy
Misra, Anoop
Gupta, Vimal
Bhatt, Surya Prakash
Ahmad Ansari, Irshad
Kehar, Sugandha
Pandey, Ravindra M
Author_xml – sequence: 1
  givenname: Sugandha
  orcidid: 0000-0001-9374-5383
  surname: Kehar
  fullname: Kehar, Sugandha
  organization: National Diabetes, Obesity and Cholesterol Foundation (N-DOC), New Delhi, India
– sequence: 2
  givenname: Surya Prakash
  orcidid: 0000-0001-9489-9747
  surname: Bhatt
  fullname: Bhatt, Surya Prakash
  organization: Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
– sequence: 3
  givenname: Ravindra M
  surname: Pandey
  fullname: Pandey, Ravindra M
  organization: Former Professor, All India Institute of Medical Sciences, New Delhi, India
– sequence: 4
  givenname: Irshad
  surname: Ahmad Ansari
  fullname: Ahmad Ansari, Irshad
  organization: Fortis C-DOC Centre for Excellence for Diabetes, Metabolic Disease, and Endocrinology, New Delhi, India
– sequence: 5
  givenname: Rajashekar Reddy
  surname: Palavalli
  fullname: Palavalli, Rajashekar Reddy
  organization: Pinaca Technology, Chennai, Tamil Nadu, India
– sequence: 6
  givenname: Vimal
  surname: Gupta
  fullname: Gupta, Vimal
  organization: Fortis C-DOC Centre for Excellence for Diabetes, Metabolic Disease, and Endocrinology, New Delhi, India
– sequence: 7
  givenname: Anoop
  orcidid: 0000-0001-5785-5833
  surname: Misra
  fullname: Misra, Anoop
  email: anoopmisra@gmail.com, anoopmisra@gmail.com, anoopmisra@gmail.com
  organization: Fortis C-DOC Centre for Excellence for Diabetes, Metabolic Disease, and Endocrinology, New Delhi, India. anoopmisra@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40946099$$D View this record in MEDLINE/PubMed
BookMark eNpNUD1PwzAUtBCIfsAfYEAeWQK2kzgxGypQkIq6hDly7JfWVRIH22nVf08pReKWO93de8NN0HlnO0DohpJ7SuL8wSc0iUlEWBoRylMR0TM0pknGo5Qn5PyfHqGJ9xtCDkbGLtEoISLhRIgx2s2bvYLWKOzA97bz4LGtcVg7ANzKbmXxVjoDwRwC02E_VBtQweOdCWssO30Udgi4YM-PWOLeNDZg5az3dgsO-zDoPR686VZ4WRTHk9n84wpd1LLxcH3iKfp8fSlmb9FiOX-fPS0iFbM8RJVWPOdVnlItc-AiY4pQkHUqaki00GmV81pXWUx1LlWiYk4zWolM1bnUJKNsiu5-__bOfg3gQ9kar6BpZAd28GXMUsJi9oMpuj1Vh6oFXfbOtNLty7-x2Dfk-m8q
ContentType Journal Article
Copyright 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Copyright_xml – notice: 2025. The Author(s), under exclusive licence to Springer Nature Limited.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1038/s41430-025-01659-1
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Anatomy & Physiology
Diet & Clinical Nutrition
EISSN 1476-5640
ExternalDocumentID 40946099
Genre Journal Article
GrantInformation_xml – fundername: Indian Council of Medical Research (ICMR)
  grantid: 5/9/1309/2020-Nut
GroupedDBID ---
-ET
-Q-
.GJ
0R~
29G
2WC
36B
39C
4.4
406
53G
5GY
5RE
6PF
70F
7RV
7X2
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
A8Z
AACDK
AAHBH
AAIKC
AAMNW
AANZL
AASML
AATNV
AAWTL
ABAKF
ABBRH
ABCQX
ABDBE
ABDBF
ABFSG
ABJNI
ABLJU
ABOCM
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACSTC
ACUHS
ACZOJ
ADBBV
ADFRT
ADHUB
AEFQL
AEJRE
AEMSY
AENEX
AEUYN
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AI.
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AN0
APEBS
ATCPS
ATHPR
AXYYD
AYFIA
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BKOMP
BNQBC
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
DIK
DNIVK
DPUIP
DU5
DWQXO
E.L
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBO
EBS
ECGQY
ECM
EE.
EHN
EIF
EIHBH
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPT
ESTFP
ESX
EX3
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HZ~
IAG
IAO
ICU
IEA
IHR
IHT
IHW
INH
INR
IOF
ITC
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M0K
M1P
M2O
M7P
NADUK
NAPCQ
NPM
NQJWS
NXXTH
O9-
OK1
OVD
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
Q~Q
RNS
RNT
RNTTT
ROL
RXW
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAE
TAOOD
TBHMF
TDRGL
TEORI
TH9
TR2
TSG
TUS
UKHRP
VH1
WH7
WOW
XOL
ZXP
~02
~8M
~KM
7X8
AAYZH
ID FETCH-LOGICAL-c328t-bdc686b851da8e6972c01eaf59fe4d9d5b86fdb731d8ac4c36171b97cf8ad0712
IEDL.DBID 7X8
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001570396800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1476-5640
IngestDate Sun Sep 14 23:52:46 EDT 2025
Sat Oct 25 02:02:08 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License 2025. The Author(s), under exclusive licence to Springer Nature Limited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c328t-bdc686b851da8e6972c01eaf59fe4d9d5b86fdb731d8ac4c36171b97cf8ad0712
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9374-5383
0000-0001-5785-5833
0000-0001-9489-9747
PMID 40946099
PQID 3250232222
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3250232222
pubmed_primary_40946099
PublicationCentury 2000
PublicationDate 2025-10-01
PublicationDateYYYYMMDD 2025-10-01
PublicationDate_xml – month: 10
  year: 2025
  text: 2025-10-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European journal of clinical nutrition
PublicationTitleAlternate Eur J Clin Nutr
PublicationYear 2025
SSID ssj0014772
Score 2.4733264
Snippet Mango consumption is often restricted in diet consumed by people with diabetes due to concerns about its glycemic impact. This study aimed to compare the...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 991
SubjectTerms Adult
Aged
Blood Glucose - analysis
Blood Glucose - metabolism
Blood Glucose Self-Monitoring
Bread
Cross-Over Studies
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - diet therapy
Diet
Female
Fruit
Glucose Tolerance Test
Glycemic Index
Humans
Male
Mangifera
Middle Aged
Pilot Projects
Postprandial Period
Title Glycemic responses of three mango varieties in subjects with and without T2D: a pilot crossover study using OTT and CGM
URI https://www.ncbi.nlm.nih.gov/pubmed/40946099
https://www.proquest.com/docview/3250232222
Volume 79
WOSCitedRecordID wos001570396800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Na9wwEBVN00MuaZu06aYfTCD0JmLLWkvupYSkSS_Z5rCFvS36DAsbext7E_LvMyN7yalQ6MU2BoGRxjNPM09vGDv2wVsTc8dNJgKXRqEf1FZxlxmSXysL5fpmE2oy0bNZdT0k3NqBVrnxiclR-8ZRjvykwFgtqCwgvq_-cOoaRdXVoYXGFtsuEMqQVavZcxVBqtS8Ce8lH5cyGw7NZIU-aSUChYxTM1c60FPx_O8QM4Wai9f_-5Fv2O4AMuG0t4q37EWo99j-aY0b7NtH-AqJ9pny6XtsdL4IHb4bBEKXMNno8--zh8vloyP2PNz1VNrQQhOhw_UPcGvqmwbuaa9NoqywqKFdW0rrtEDZXTC1Tw_NuoOpOP8GBlaLZdNBisxEHYUkbgvEvb-BX9NpGnJ2efWO_b74MT37yYdODdwVQnfcelfq0iJ680aHslLCZXkwcVzFIH3lx1aX0VtV5F4bJ12BuCm3lXJRG48gR7xnL-umDh8YKONFFvMQMLhKnVmjXa7RoISK0UvpR-xoM_Vz_BOovGHq0Kzb-fPkj9hBv37zVS_ZMaddbIlg-PAfRn9kO4LsIjH2PrHtiH4gfGav3H23aO--JBPD6-T66gm3t9xm
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycemic+responses+of+three+mango+varieties+in+subjects+with+and+without+T2D%3A+a+pilot+crossover+study+using+OTT+and+CGM&rft.jtitle=European+journal+of+clinical+nutrition&rft.au=Kehar%2C+Sugandha&rft.au=Bhatt%2C+Surya+Prakash&rft.au=Pandey%2C+Ravindra+M&rft.au=Ahmad+Ansari%2C+Irshad&rft.date=2025-10-01&rft.eissn=1476-5640&rft.volume=79&rft.issue=10&rft.spage=991&rft_id=info:doi/10.1038%2Fs41430-025-01659-1&rft_id=info%3Apmid%2F40946099&rft_id=info%3Apmid%2F40946099&rft.externalDocID=40946099
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-5640&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-5640&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-5640&client=summon